Researchers have discovered an unexpected use for virtual reality headsets to enable physicians pinpoint individuals who may later develop Alzheimer’s disease.
Alzheimer’s, a brain disease that causes a slow decline in memory, reasoning and thinking skills, is the most common reason for dementia, the general term for other memory cognition capacities serious enough to interfere with everyday life. Alzheimer’s illness accounts 60 to 80 percent of dementia cases. The aim of the scientists in the virtual reality headset test is to recognize potential Alzheimer’s disease patients far earlier than is possible at present and in the long term develop aimed at halting or slowing their condition.
“To date, drug trials for Alzheimer’s have been applied when individuals have just got dementia, by which time consideration damage to the brain had already occurred,” said Dennis Chan, the project leader and neuroscientist based at Cambridge University. He stated, “The entorhinal cortex is the first brain region to show to degeneration when you get Alzheimer’s, and that is where we shall be focusing our research.
“If we can develop drugs and can administer them earlier, for instance before the disease has spread beyond the entorhinal cortex, then this would have the potentials to prevent the onset of dementia.